GlassScriptPhysician profile
Travis Howard
NPI 1235591215
$10,900.33
in general payments reported to CMS, 2019-2025
28 companies · $3,900 in 2025
The $3,900 reported for 2025 was more than what 79% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,502 · 2023: $1,796 · 2024: $3,703 · 2025: $3,900.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,016 · Travel and Lodging: $2,831 · Consulting Fee: $530 · Education: $21.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,016.47 |
| Travel and Lodging | $2,830.81 |
| Consulting Fee | $530.00 |
| Education | $21.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,480.81 | 2022-2025 | Triclip, Mitraclip, Navitor |
| Edwards Lifesciences Corporation | $2,368.67 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Boston Scientific Corporation | $923.81 | 2022-2024 | Avvigo Guidance System, Opticross, Crossboss |
| Abiomed | $615.05 | 2023-2025 | Impella |
| Shockwave Medical, INC | $532.18 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cvrx, INC. | $405.21 | 2024-2025 | Barostim Neo System |
| Medtronic, INC. | $297.85 | 2022-2023 | Hawkone, Corevalve Evolut R |
| Novo Nordisk INC | $189.31 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Cardiva Medical, INC. | $182.51 | 2022-2025 | Savvywire, Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Zoll Circulation INC | $168.50 | 2025 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Philips North America LLC | $164.35 | 2022-2025 | Coronary Undivided |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $128.66 | 2023-2025 | Lifevest |
| Cardiovascular Systems INC. | $66.16 | 2022-2023 | Diamondback Coronary |
| Bayer Healthcare Pharmaceuticals INC. | $44.35 | 2025 | |
| Novartis Pharmaceuticals Corporation | $40.73 | 2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verge Medical, INC. | $38.07 | 2023 | |
| Biotronik INC. | $36.22 | 2023-2024 | Orsiro Mission, Recross, Pk Papyrus |
| Actelion Pharmaceuticals US, INC. | $28.58 | 2025 | Uptravi |
| Ge Healthcare | $25.32 | 2025 | |
| Heartflow, INC. | $23.94 | 2025 | |
| Penumbra, INC. | $20.38 | 2023 | Indigo System |
| Esperion Therapeutics, INC. | $20.34 | 2025 | Nexletol |
| Terumo Medical Corporation | $18.94 | 2022 | |
| Livanova USA, INC. | $17.60 | 2023 | Lifesparc |
| W. L. Gore & Associates, INC. | $16.67 | 2024 | Gore Cardioform Septal Occluder |
| Teleflex LLC | $16.01 | 2022 | |
| Amgen INC. | $15.43 | 2025 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.68 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.